Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 25/100 | DilutionWatch score record |
| Shares Outstanding | 326.62M | Verified float table or market cache |
| Public Float | 206.94M | Verified float table or market cache |
| Market Cap | $3.42B | Market data cache |
| Cash Runway | 15.0 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | None in current score inputs | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 5.
Recent SEC source mix: FORM 4 5.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
ABCL SEC Filing Activity — Last 12 Months
Shares outstanding reported by ABCL on the cover page of its latest 10-K/10-Q: 326.62M as of November 04, 2026.
DilutionWatch recorded 1 registration or prospectus document for ABCL (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| 424B5 | prospectus supplement (ATM / shelf takedown) | 1 | Aug 11, 2026 |
| 8-K | current report (material event) | 2 | Nov 09, 2026 |
| 10-Q | quarterly report | 1 | Nov 09, 2026 |
| SC 13G/A | amended passive >5% holder filing | 1 | Nov 13, 2026 |
| 4 | insider transaction | 7 | Nov 16, 2026 |
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual ABCL Dilution Snapshot
AbCellera Biologics Inc. (ABCL) has a DilutionScore of 25/100, rated Low dilution risk. Score date: November 20, 2026.
- Recent SEC activity tracked for ABCL: Form 4 (x4) on 2026-11-13; Form 4 on 2026-11-12.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
ABCL's DilutionScore is currently 25/100 (Low risk), with 1 score change tracked over 89 days. The score deteriorated from 35/100 (Medium risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Nov 16 – Nov 20, 2026 | 25/100 | LOW | 5 days |
| Aug 24 – Nov 15, 2026 | 35/100 | MEDIUM | 84 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
ABCL shares outstanding have increased 6.5% from 306.61M (Nov 2026) to 326.62M (Nov 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| Nov 21, 2026 | 326.62M | 206.94M | — |
| Nov 16, 2026 | 326.62M | 206.94M | — |
| Nov 10, 2026 | 306.61M | 206.94M | — |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — LOW Risk
Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.